BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22732331)

  • 1. Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.
    Kalil RS; Flanigan M; Stanford W; Haynes WG
    Clin Nephrol; 2012 Jul; 78(1):1-9. PubMed ID: 22732331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.
    Ohtake T; Kobayashi S; Oka M; Furuya R; Iwagami M; Tsutsumi D; Mochida Y; Maesato K; Ishioka K; Moriya H; Hidaka S
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):439-46. PubMed ID: 23615577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
    Di Iorio B; Bellasi A; Russo D;
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):487-93. PubMed ID: 22241819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
    Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
    Nephrology (Carlton); 2011 Mar; 16(3):290-8. PubMed ID: 21342323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial.
    Ogata H; Fukagawa M; Hirakata H; Kagimura T; Akizawa T;
    Clin Exp Nephrol; 2022 Dec; 26(12):1223-1232. PubMed ID: 36064876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
    Qunibi W; Moustafa M; Muenz LR; He DY; Kessler PD; Diaz-Buxo JA; Budoff M;
    Am J Kidney Dis; 2008 Jun; 51(6):952-65. PubMed ID: 18423809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.
    Watanabe K; Fujii H; Kono K; Goto S; Nishi S
    BMC Cardiovasc Disord; 2020 Jan; 20(1):39. PubMed ID: 32000687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
    Toida T; Fukudome K; Fujimoto S; Yamada K; Sato Y; Chiyotanda S; Kitamura K
    Clin Nephrol; 2012 Sep; 78(3):216-23. PubMed ID: 22874110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of non-calcium-based phosphate binders versus calcium-based phosphate binders on cardiovascular calcification and bone remodeling among dialysis patients: a meta-analysis of randomized trials.
    Liu L; Wang Y; Chen H; Zhu X; Zhou L; Yang Y
    Ren Fail; 2014 Sep; 36(8):1244-52. PubMed ID: 25019348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
    Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.
    Rastogi A
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
    Russo D; Bellasi A; Pota A; Russo L; Di Iorio B
    J Nephrol; 2015 Feb; 28(1):73-80. PubMed ID: 24599830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Lanthanum Carbonate on Coronary Artery Calcification and Cardiac Abnormalities After Initiating Hemodialysis.
    Fujii H; Kono K; Nakai K; Goto S; Nishii T; Kono A; Nishi S
    Calcif Tissue Int; 2018 Mar; 102(3):310-320. PubMed ID: 29058057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
    Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
    Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.
    Sprague SM; Ross EA; Nath SD; Zhang P; Pratt RD; Krause R
    Clin Nephrol; 2009 Oct; 72(4):252-8. PubMed ID: 19825330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study.
    Zhang C; Wang S; Zhao S; Zhang X
    Medicine (Baltimore); 2017 Nov; 96(45):e8664. PubMed ID: 29137107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.
    Lemos MM; Watanabe R; Carvalho AB; Jancikic AD; Sanches FM; Christofalo DM; Draibe SA; Canziani ME
    Clin Nephrol; 2013 Jul; 80(1):1-8. PubMed ID: 23442255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized crossover study of the efficacy and safety of sevelamer hydrochloride and lanthanum carbonate in Japanese patients undergoing hemodialysis.
    Kasai S; Sato K; Murata Y; Kinoshita Y
    Ther Apher Dial; 2012 Aug; 16(4):341-9. PubMed ID: 22817122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
    Prajapati VA; Galani VJ; Shah PR
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):530-8. PubMed ID: 24821148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.